Implementation of the Short-Form 36 (SF-36) in childhood cancer survivors: An analysis on measurement properties across 5 European countries
Katja Baust(University Hospital Bonn), Grit Sommer(University of Bern), Heleen Maurice‐Stam(Princess Máxima Center), Gabriele Calaminus(University Hospital Bonn), Claire Berger(Inserm), Marry M. van den Heuvel‐Eibrink(Princess Máxima Center), Tomáš Kepák(Masaryk University), Julianne Byrne(Boyne Research Institute), Claudia Spix(Johannes Gutenberg University Mainz), Leontien C.M. Kremer(University Medical Center Utrecht), Katharina Roser(University of Lucerne), Rahel Kuonen(University of Bern), Jarmila Kruseová(Charles University), Melanie Kaiser(Johannes Gutenberg University Mainz), D Grabow(Johannes Gutenberg University Mainz), Claudia E. Kuehni(University of Bern)
Cited by 2
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553